Advertisements


Iovance reports objective response rate of 37% in Cohort 2 of C-144-01 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Iovance reports 27% objective response rate in study of cervical carcinoma

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

TG Therapeutics reports data from MZL cohort of Phase 2b UNITY-NHL trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2019

Nektar reports 48% overall response rate in urothelial cancer for NKTR-214 combo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 12th, 2019

Kadmon reports KD025 trial ORR 65% in Cohort 1%, 63% in Cohort 2

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 3rd, 2018

Novo Nordisk reports PIONEER 9 trial successfully achieved primary objective

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 23rd, 2018

Sellas Life Sciences reports 1-year PFS rate of 70% in Phase 1 combination trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

TSMC CEO says 7nm utilization rate to rise in 2H19, Digitimes reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 22nd, 2019

American Express reports March net write-off rate 2.5% vs. 2.4% prior month

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Bank of America reports March default rate 2.78% vs. 2.62% last month

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Mallinckrodt reports retrospective analysis on Phase 3 REVERSE trial data at ILC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Synchrony reports March net charge off rate 5.24% vs. 4.98% last month

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Axsome reports Duke University completed analysis of Phase 2 trial of AXS-05

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2019

Opko Health reports additional results from Phase 2 OPK-88003 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 12th, 2019

Sub-Saharan Africa"s growth rate slashed

The World Bank has cut the economic growth rate of Sub-Saharan Africa to 2.8 percent this year, as the region again fails to meet expected targets. Sam Holder reports......»»

Category: videoSource: reutersApr 10th, 2019

Will Functional Genomics Cure Big Pharma’s Failure Rate?

GSK's R&D chief is making bets. Drug discovery is a notoriously expensive and inefficient endeavor. Nine of 10 drug candidates that go through the cost-intensive, years-long clinical trial process never make it to market. That 90% failure rate--a.....»»

Category: europeSource: fortuneApr 9th, 2019

Johnson & Johnson wins trial over man"s talc-cancer claim, Bloomberg reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 7th, 2019

AstraZeneca reports publication of Fasenra Phase 2 trial results in NEJM

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 4th, 2019

Iovance Biotherapeutics doses first patient in in Cohort 4 of innovaTIL-01 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 2nd, 2019

Autolus reports initial results from ALLCAR19 Phase 1/2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2019

Auris Medical announces randomization of first cohort in AM-201 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 29th, 2019